Loading...
XMAD
PRM
Market cap274mUSD
Dec 05, Last price  
13.85EUR
1D
0.00%
1Q
13.06%
Jan 2017
55.62%
Name

Prim SA

Chart & Performance

D1W1MN
XMAD:PRM chart
P/E
21.58
P/S
1.01
EPS
0.64
Div Yield, %
2.43%
Shrs. gr., 5y
-0.36%
Rev. gr., 5y
9.08%
Revenues
233m
+7.68%
71,953,99190,542,33291,630,05295,760,93795,496,61895,111,84091,446,38488,662,28387,000,32794,205,58299,227,781110,099,596121,272,878134,429,946150,998,844147,323,948168,512,431197,245,073216,510,625233,147,000
Net income
11m
-13.83%
5,710,8347,554,94710,060,2179,903,88910,034,9228,531,9608,908,8609,135,1439,634,2689,961,52710,702,84713,096,66213,897,88114,118,96311,218,1256,917,30117,422,5908,391,26812,672,57010,920,000
CFO
22m
P
000000000012,245,80611,596,29512,438,4136,574,479652,23725,958,90526,304,7934,889,666-31,245,06522,105,000
Dividend
Jul 17, 20240.2269 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Prim, S.A., through its subsidiaries, designs, manufactures, and commercializes orthopedic products for physiotherapy, thalassotherapy, hydrotherapy, rehabilitation, spa, geriatrics, and support techniques in Spain and internationally. The company offers products for neuro-trauma, cardiovascular, neuromodulation, operating rooms, endo-surgery, plastic surgery, and ENT. It also engages in management of wellness projects, including hotels, resorts, and club sports. Prim, S.A. was founded in 1870 and is headquartered in Móstoles, Spain.
IPO date
Jan 21, 1997
Employees
827
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT